The Slovak Republic became part of the international research infrastructure ECRIN (European Clinical Research Infrastructure Network) in 2018. The European Clinical Research Infrastructure Network (ECRIN) is a not-for-profit intergovernmental organisation that supports the conduct of multinational clinical trials in Europe. As of 2013, ECRIN has the legal status of a European Research Infrastructure Consortium (ERIC).
ECRIN currently has 9 Member Countries (the Czech Republic, France, Germany, Hungary, Ireland, Italy, Norway, Portugal and Spain) and two Observer Countries (Switzerland and Slovakia). Each country has a EuCo who links the national clinical research network to the ECRIN Core Team and other countries, manages the clinical trial portfolio and coordinates with the national scientific partner with support from the Paris-based Core Team.
SLOVACRIN (Slovak Clinical Research Infrastructure Network) is a national research infrastructure network connecting hospitals, universities and scientific institutions involved in academic clinical research. SLOVACRIN is coordinated by the Faculty of Medicine of the Pavol Jozef Safarik University in Kosice. General director of SLOVACRIN and dean of the Faculty of Medicine is prof. Daniel Pella. SLOVACRIN supports the preparation and implementation of academic clinical trials in Slovakia, including international trials. The aim is to increase the number and quality of academically initiated clinical trials in Slovakia, using the available capacity and expertise to ensure compliance with regulatory, legislative and ethical requirements related to clinical research.
During the first year of its activity, SLOVACRIN supported several academical studies, especially in the field of oncology. As part of development projects, the Slovak Republic, through this infrastructure, has been involved in both ‘the EOSC Life project’; which maps the possibility of sharing data in clinical trials and in ‘the Pharmacovigilance Standardization project for drug safety surveillance in clinical trials’. SLOVACRIN is also involved in organizing the training of clinical trial coordinators in healthcare facilities and training doctors – researchers and healthcare professionals in the field of good clinical practice and pharmacovigilance. SLOVACRIN is currently preparing a Roadmap for Research Infrastructures for Academic Clinical Trials.